![Eric Lev](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Lev
Presidente presso
GeneProof AS
Profilo
Eric B. Lev is currently the Chairman-Supervisory Board at GeneProof AS, Director at LakePharma, Inc., Director at Canopy Biosciences LLC, Director at NEOMED-LABS, Inc., Director at Nexelis Laboratories Canada, Inc., General Partner at Ampersand Management LLC, and Board Member at Alcami Carolinas Corp.
Previously, he served as the Chairman at PLUS Diagnostics, Inc., Independent Director at Interpace Biosciences, Inc., Director at Genoptix, Inc., Director at ConVerge Diagnostic Services LLC, Director at Azurity Pharmaceuticals, Inc., Group Manager-Strategy & Business Development at Beckman Coulter, Inc., Founding Member at Water Street Healthcare Partners LLC, and Principal at OEP Capital Advisors LP.
He completed his undergraduate degree at Northwestern University in 1998 and holds an MBA from The University of Chicago.
Posizioni attive di Eric Lev
| Società | Posizione | Inizio |
|---|---|---|
Alcami Carolinas Corp.
 Alcami Carolinas Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development services | Corporate Officer/Principal | - |
Ampersand Management LLC
 Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Investitore di Private Equity | 25/02/2013 |
Canopy Biosciences LLC
 Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures research tools for targeted genome editing, molecular biology and personalized medicine | Direttore/Membro del Consiglio | - |
Nexelis Laboratories Canada, Inc.
 Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Direttore/Membro del Consiglio | - |
NEOMED-LABS, Inc.
 NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Direttore/Membro del Consiglio | - |
LakePharma, Inc.
 LakePharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract research organization that specializes in antibody and protein engineering, cell line development, and protein production | Direttore/Membro del Consiglio | - |
GeneProof AS
 GeneProof AS Medical SpecialtiesHealth Technology Operates as a molecular diagnostics company | Presidente | 08/04/2022 |
Precedenti posizioni note di Eric Lev
| Società | Posizione | Fine |
|---|---|---|
| INTERPACE BIOSCIENCES, INC. | Direttore/Membro del Consiglio | 01/02/2022 |
ConVerge Diagnostic Services LLC
 ConVerge Diagnostic Services LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Direttore/Membro del Consiglio | 30/05/2018 |
| ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
| ░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ | - |
Formazione di Eric Lev
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
97
Relazioni di 1° grado
17
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 17 |
|---|---|
Interpace Biosciences, Inc.
 Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Beckman Coulter, Inc.
 Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes biomedical testing instrument systems and general biomedical research products | Health Technology |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Ampersand Management LLC
Ampersand Management LLC Investment ManagersFinance Ampersand Management invests in companies located in North America, Europe and APAC with an EBITDA of USD 2 - 40 million and revenues of USD 10 - 200 million. The firm targets companies operating in the fields of contract manufacturing, pharma services, specialty products, laboratory products and laboratory services. It participates in MBOs, corporate divestitures, recapitalization and growth stage capital requirements with an investment size of USD 10 - 200 million. The firm acquires majority and minority interests. | Finance |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PLUS Diagnostics, Inc.
 PLUS Diagnostics, Inc. Medical/Nursing ServicesHealth Services Provides anatomic pathology services | Health Services |
Alcami Carolinas Corp.
Alcami Carolinas Corp. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical development services | Health Technology |
ConVerge Diagnostic Services LLC
ConVerge Diagnostic Services LLC Medical/Nursing ServicesHealth Services Provides laboratory services | Health Services |
Water Street Healthcare Partners LLC
 Water Street Healthcare Partners LLC Investment ManagersFinance Water Street Healthcare invests in companies located in the United States. The firm focuses on the healthcare sector such as pharmaceutical & life sciences, medical products & diagnostics and healthcare services sectors. It participates in growth and buyout stage capital transactions. | Finance |
OEP Capital Advisors LP
 OEP Capital Advisors LP Investment ManagersFinance OEP Capital Advisors invests in middle market companies located in North America and Europe with EBITDA of USD 10 - 70 million and revenues of $100 to $800 million. The firm focuses on sectors of technology, industrial and healthcare with an investment size of $30 to $300 million. It provides financing for buyout transactions and acquires controlling stake. | Finance |
LakePharma, Inc.
LakePharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract research organization that specializes in antibody and protein engineering, cell line development, and protein production | Health Technology |
GeneProof AS
GeneProof AS Medical SpecialtiesHealth Technology Operates as a molecular diagnostics company | Health Technology |
Canopy Biosciences LLC
Canopy Biosciences LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures research tools for targeted genome editing, molecular biology and personalized medicine | Electronic Technology |
NEOMED-LABS, Inc.
NEOMED-LABS, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Nexelis Laboratories Canada, Inc.
Nexelis Laboratories Canada, Inc. BiotechnologyHealth Technology Operates as a immunology-centric contract research organization | Health Technology |
Azurity Pharmaceuticals, Inc.
 Azurity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
